[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Nuclear Medicine Market Report 2017

December 2017 | 100 pages | ID: A0AD389456BEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Nuclear Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nuclear Medicine for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Nuclear Medicine market competition by top manufacturers/players, with Nuclear Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Mallinckrodt
  • Medtronic
  • General Electric
  • GlaxoSmithKline
  • Cardinal Health
  • Lantheus Medical Imaging
  • IBA
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Diagnostic
  • Therapeutic
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Nuclear Medicine Market Report 2017

1 NUCLEAR MEDICINE OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine
1.2 Classification of Nuclear Medicine by Product Category
  1.2.1 Asia-Pacific Nuclear Medicine Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Nuclear Medicine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Diagnostic
  1.2.4 Therapeutic
1.3 Asia-Pacific Nuclear Medicine Market by Application/End Users
  1.3.1 Asia-Pacific Nuclear Medicine Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Oncology
  1.3.3 Cardiology
  1.3.4 Neurology
  1.3.5 Thyroid
  1.3.6 Others
1.4 Asia-Pacific Nuclear Medicine Market by Region
  1.4.1 Asia-Pacific Nuclear Medicine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Nuclear Medicine (2012-2022)
  1.5.1 Asia-Pacific Nuclear Medicine Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Nuclear Medicine Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC NUCLEAR MEDICINE COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Nuclear Medicine Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Nuclear Medicine Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Nuclear Medicine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Nuclear Medicine (Volume and Value) by Type
  2.2.1 Asia-Pacific Nuclear Medicine Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Nuclear Medicine Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Nuclear Medicine (Volume) by Application
2.4 Asia-Pacific Nuclear Medicine (Volume and Value) by Region
  2.4.1 Asia-Pacific Nuclear Medicine Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Nuclear Medicine Revenue and Market Share by Region (2012-2017)

3 CHINA NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE)

3.1 China Nuclear Medicine Sales and Value (2012-2017)
  3.1.1 China Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Nuclear Medicine Revenue and Growth Rate (2012-2017)
  3.1.3 China Nuclear Medicine Sales Price Trend (2012-2017)
3.2 China Nuclear Medicine Sales Volume and Market Share by Type
3.3 China Nuclear Medicine Sales Volume and Market Share by Application

4 JAPAN NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Nuclear Medicine Sales and Value (2012-2017)
  4.1.1 Japan Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Nuclear Medicine Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Nuclear Medicine Sales Price Trend (2012-2017)
4.2 Japan Nuclear Medicine Sales Volume and Market Share by Type
4.3 Japan Nuclear Medicine Sales Volume and Market Share by Application

5 SOUTH KOREA NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Nuclear Medicine Sales and Value (2012-2017)
  5.1.1 South Korea Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Nuclear Medicine Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Nuclear Medicine Sales Price Trend (2012-2017)
5.2 South Korea Nuclear Medicine Sales Volume and Market Share by Type
5.3 South Korea Nuclear Medicine Sales Volume and Market Share by Application

6 TAIWAN NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Nuclear Medicine Sales and Value (2012-2017)
  6.1.1 Taiwan Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Nuclear Medicine Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Nuclear Medicine Sales Price Trend (2012-2017)
6.2 Taiwan Nuclear Medicine Sales Volume and Market Share by Type
6.3 Taiwan Nuclear Medicine Sales Volume and Market Share by Application

7 INDIA NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE)

7.1 India Nuclear Medicine Sales and Value (2012-2017)
  7.1.1 India Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Nuclear Medicine Revenue and Growth Rate (2012-2017)
  7.1.3 India Nuclear Medicine Sales Price Trend (2012-2017)
7.2 India Nuclear Medicine Sales Volume and Market Share by Type
7.3 India Nuclear Medicine Sales Volume and Market Share by Application

8 SOUTHEAST ASIA NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Nuclear Medicine Sales and Value (2012-2017)
  8.1.1 Southeast Asia Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Nuclear Medicine Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Nuclear Medicine Sales Price Trend (2012-2017)
8.2 Southeast Asia Nuclear Medicine Sales Volume and Market Share by Type
8.3 Southeast Asia Nuclear Medicine Sales Volume and Market Share by Application

9 AUSTRALIA NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Nuclear Medicine Sales and Value (2012-2017)
  9.1.1 Australia Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Nuclear Medicine Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Nuclear Medicine Sales Price Trend (2012-2017)
9.2 Australia Nuclear Medicine Sales Volume and Market Share by Type
9.3 Australia Nuclear Medicine Sales Volume and Market Share by Application

10 ASIA-PACIFIC NUCLEAR MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Mallinckrodt
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Nuclear Medicine Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Mallinckrodt Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Medtronic
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Nuclear Medicine Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Medtronic Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 General Electric
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Nuclear Medicine Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 General Electric Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 GlaxoSmithKline
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Nuclear Medicine Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 GlaxoSmithKline Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Cardinal Health
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Nuclear Medicine Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Cardinal Health Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Lantheus Medical Imaging
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Nuclear Medicine Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Lantheus Medical Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 IBA
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Nuclear Medicine Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 IBA Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview

11 NUCLEAR MEDICINE MANUFACTURING COST ANALYSIS

11.1 Nuclear Medicine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Nuclear Medicine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Nuclear Medicine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Nuclear Medicine Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC NUCLEAR MEDICINE MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Nuclear Medicine Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Nuclear Medicine Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Nuclear Medicine Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Nuclear Medicine Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Nuclear Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Nuclear Medicine Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Nuclear Medicine Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Nuclear Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Nuclear Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Nuclear Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Nuclear Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Nuclear Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Nuclear Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Nuclear Medicine Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Nuclear Medicine Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Nuclear Medicine Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Nuclear Medicine Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Nuclear Medicine Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Nuclear Medicine Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Medicine
Figure Asia-Pacific Nuclear Medicine Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Nuclear Medicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Product Picture
Figure Therapeutic Product Picture
Figure Asia-Pacific Nuclear Medicine Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Nuclear Medicine by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Thyroid Examples
Table Key Downstream Customer in Thyroid
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Nuclear Medicine Market Size (Million USD) by Region (2012-2022)
Figure China Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Nuclear Medicine Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Nuclear Medicine Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Nuclear Medicine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Nuclear Medicine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Nuclear Medicine Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Nuclear Medicine Sales Share by Players/Suppliers
Figure Asia-Pacific Nuclear Medicine Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Nuclear Medicine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Nuclear Medicine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Nuclear Medicine Revenue Share by Players
Figure 2017 Asia-Pacific Nuclear Medicine Revenue Share by Players
Table Asia-Pacific Nuclear Medicine Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Nuclear Medicine Sales Share by Type (2012-2017)
Figure Sales Market Share of Nuclear Medicine by Type (2012-2017)
Figure Asia-Pacific Nuclear Medicine Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Nuclear Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Nuclear Medicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine by Type (2012-2017)
Figure Asia-Pacific Nuclear Medicine Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Nuclear Medicine Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Nuclear Medicine Sales Share by Region (2012-2017)
Figure Sales Market Share of Nuclear Medicine by Region (2012-2017)
Figure Asia-Pacific Nuclear Medicine Sales Market Share by Region in 2016
Table Asia-Pacific Nuclear Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Nuclear Medicine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Nuclear Medicine by Region (2012-2017)
Figure Asia-Pacific Nuclear Medicine Revenue Market Share by Region in 2016
Table Asia-Pacific Nuclear Medicine Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Nuclear Medicine Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Nuclear Medicine Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Nuclear Medicine Sales Market Share by Application (2012-2017)
Figure China Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure China Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table China Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table China Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure China Nuclear Medicine Sales Volume Market Share by Type in 2016
Table China Nuclear Medicine Sales Volume (K Units) by Applications (2012-2017)
Table China Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure China Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure Japan Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table Japan Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure Japan Nuclear Medicine Sales Volume Market Share by Type in 2016
Table Japan Nuclear Medicine Sales Volume (K Units) by Applications (2012-2017)
Table Japan Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure Japan Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure South Korea Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table South Korea Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure South Korea Nuclear Medicine Sales Volume Market Share by Type in 2016
Table South Korea Nuclear Medicine Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure South Korea Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure Taiwan Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Nuclear Medicine Sales Volume Market Share by Type in 2016
Table Taiwan Nuclear Medicine Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure India Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure India Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table India Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table India Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure India Nuclear Medicine Sales Volume Market Share by Type in 2016
Table India Nuclear Medicine Sales Volume (K Units) by Application (2012-2017)
Table India Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure India Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure Southeast Asia Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Nuclear Medicine Sales Volume Market Share by Type in 2016
Table Southeast Asia Nuclear Medicine Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Nuclear Medicine Sales Volume Market Share by Application in 2016
Figure Australia Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Nuclear Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Nuclear Medicine Sales Volume (K Units) by Type (2012-2017)
Table Australia Nuclear Medicine Sales Volume Market Share by Type (2012-2017)
Figure Australia Nuclear Medicine Sales Volume Market Share by Type in 2016
Table Australia Nuclear Medicine Sales Volume (K Units) by Applications (2012-2017)
Table Australia Nuclear Medicine Sales Volume Market Share by Application (2012-2017)
Figure Australia Nuclear Medicine Sales Volume Market Share by Application in 2016
Table Mallinckrodt Nuclear Medicine Basic Information List
Table Mallinckrodt Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mallinckrodt Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Mallinckrodt Nuclear Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Mallinckrodt Nuclear Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Medtronic Nuclear Medicine Basic Information List
Table Medtronic Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic Nuclear Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Medtronic Nuclear Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table General Electric Nuclear Medicine Basic Information List
Table General Electric Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure General Electric Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure General Electric Nuclear Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure General Electric Nuclear Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Nuclear Medicine Basic Information List
Table GlaxoSmithKline Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Nuclear Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Nuclear Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Cardinal Health Nuclear Medicine Basic Information List
Table Cardinal Health Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cardinal Health Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Cardinal Health Nuclear Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Cardinal Health Nuclear Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Lantheus Medical Imaging Nuclear Medicine Basic Information List
Table Lantheus Medical Imaging Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table IBA Nuclear Medicine Basic Information List
Table IBA Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IBA Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure IBA Nuclear Medicine Sales Market Share in Asia-Pacific (2012-2017)
Figure IBA Nuclear Medicine Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine
Figure Manufacturing Process Analysis of Nuclear Medicine
Figure Nuclear Medicine Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine Major Manufacturers in 2016
Table Major Buyers of Nuclear Medicine
Table Distributors/Traders List
Figure Asia-Pacific Nuclear Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Nuclear Medicine Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Nuclear Medicine Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Nuclear Medicine Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Nuclear Medicine Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Nuclear Medicine Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Nuclear Medicine Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Nuclear Medicine Revenue Market Share Forecast by Region in 2022
Figure China Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Nuclear Medicine Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Nuclear Medicine Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Nuclear Medicine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Nuclear Medicine Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Nuclear Medicine Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Nuclear Medicine Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Nuclear Medicine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories